Yousif Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.02M Buy
23,189
+316
+1% +$19.1K 0.02% 684
2026
Q1
$922K Sell
22,873
-313
-1% -$11.7K 0.01% 1101
2025
Q4
$818K Sell
23,186
-1,090
-4% -$85.6K 0.01% 1178
2025
Q3
$2.02M Sell
24,276
-3,622
-13% -$262K 0.02% 713
2025
Q2
$2.05M Buy
27,898
+697
+3% +$50.5K 0.02% 724
2025
Q1
$3.11M Sell
27,201
-759
-3% -$46.2K 0.04% 484
2024
Q4
$1.41M Sell
27,960
-516
-2% -$27K 0.02% 950
2024
Q3
$1.32M Sell
28,476
-817
-3% -$29K 0.01% 1004
2024
Q2
$952K Sell
29,293
-4,002
-12% -$110K 0.01% 1166
2024
Q1
$839K Sell
33,295
-3,655
-10% -$86.4K 0.01% 1291
2023
Q4
$1.2M Sell
36,950
-2,580
-7% -$70.8K 0.01% 1129
2023
Q3
$1.08M Sell
39,530
-3,189
-7% -$92.3K 0.01% 1101
2023
Q2
$950K Sell
42,719
-6,360
-13% -$146K 0.01% 1194
2023
Q1
$1.06M Sell
49,079
-7,900
-14% -$173K 0.01% 1116
2022
Q4
$1.16M Sell
56,979
-13,300
-19% -$333K 0.02% 1090
2022
Q3
$1.8M Sell
70,279
-1,630
-2% -$43.6K 0.03% 810
2022
Q2
$1.71M Sell
71,909
-8,425
-10% -$184K 0.02% 919
2022
Q1
$1.81M Sell
80,334
-1,975
-2% -$42K 0.02% 1005
2021
Q4
$1.63M Buy
+82,309
New +$1.67M 0.02% 1122

Other funds holding CORT

Yousif Capital Management's CORT Position: Q2 2026 in Review

Yousif Capital Management increased its Corcept Therapeutics (CORT) stake by 1.4% in Q2 2026, buying an estimated $19.1K and bringing the position to 23,189 shares worth $2.02M. The position accounts for 0.02% of the portfolio, ranked #684.

Yousif Capital Management first reported a position in CORT in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.11M in Q1 2025. 61 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Yousif Capital Management held 23,189 shares of Corcept Therapeutics worth $2.02M as of Q2 2026.
  • Yousif Capital Management bought 316 Corcept Therapeutics shares in Q2 2026, an estimated $19.1K.
  • Corcept Therapeutics made up 0.02% of Yousif Capital Management's portfolio in Q2 2026, its #684 holding.
  • Yousif Capital Management first reported a position in Corcept Therapeutics in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Corcept Therapeutics position peaked at $3.11M in Q1 2025.
  • 61 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.